Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
166 hedge funds and large institutions have $1.9B invested in Medicines Co in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 38 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less call options, than puts
Call options by funds: $13.6M | Put options by funds: $14.1M
9% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 65
9% less funds holding
Funds holding: 182 → 166 (-16)
27% less capital invested
Capital invested by funds: $2.6B → $1.9B (-$710M)
37% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$51.7M |
| 2 |
RA
Royce & Associates
New York
|
+$50.1M |
| 3 |
PC
PointState Capital
New York
|
+$48.9M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$20.9M |
| 5 |
D.E. Shaw & Co
New York
|
+$20.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$81.7M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$30.3M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$25.5M |
| 4 |
BM
Bridger Management
New York
|
-$24.3M |
| 5 |
O
OppenheimerFunds
New York
|
-$18.7M |
MDCO Hedge Fund Activity: Q1 2014 in Review
166 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2014, worth a combined $1.9B — down 27% from $2.6B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of MDCO and 24 opened new positions — a net loss of 14 holders — while 65 trimmed existing stakes and 59 added.
The largest buyer was Fidelity Investments, adding an estimated $51.7M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $81.7M sold.
- 166 institutional investors held Medicines Co (MDCO) as of Q1 2014, down from 182 in Q4 2013.
- Funds reported $1.9B of Medicines Co stock for Q1 2014, down 27% quarter-over-quarter.
- 24 funds opened new Medicines Co positions in Q1 2014 and 38 closed out, a net change of -14 holders.
- The largest Medicines Co buyer in Q1 2014 was Fidelity Investments, an estimated $51.7M added.
- The largest Medicines Co seller in Q1 2014 was PFM Health Sciences, an estimated $81.7M sold.
Based on aggregated 13F filings for Q1 2014.